Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H van Den Hoogen

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|August 20, 2003
[The anti-synthetase syndrome: muscle disease and multisystem disorder at the same time]G J Hengstman, W J van Venrooij, F H van den Hoogen, et al.
Journal of Immunological Methods|January 23, 1999
Peripheral blood monocytes of rheumatoid arthritis patients do not express elevated TNF alpha, IL-1beta, and IL-8 mRNA levels. A comparison of monocyte isolation proceduresR J Rodenburg, F H van den Hoogen, L B van de Putte, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 1994
Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damageG T Venneker, F H van den Hoogen, A M Boerbooms, et al.
Acta Orthopaedica Scandinavica|June 1, 1997
Shoulder hemiarthroplasty in rheumatoid arthritis. 19 cases reexamined after 1-17 yearsR C Koorevaar, N D Merkies, M C de Waal Malefijt, et al.
American Journal of Medical Genetics|June 13, 1997
Oto- spondylo-megaepiphyseal dysplasia (OSMED): clinical description of three patients homozygous for a missense mutation in the COL11A2 geneM A van Steensel, P Buma, M C de Waal Malefijt, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 29, 1998
[High-dose chemotherapy followed by hematopoietic stem cell transplantation as therapy for systemic rheumatic autoimmune diseases]F H van den Hoogen, A V Schattenberg, F C Breedveld, et al.
Molecular Biology Reports|May 1, 1992
Analysis of an immunodominant epitope of topoisomerase I in patients with systemic sclerosisT M Meesters, M Hoet, F H van den Hoogen, et al.
Annals of the Rheumatic Diseases|September 24, 1999
Superinduction of interleukin 8 mRNA in activated monocyte derived macrophages from rheumatoid arthritis patientsR J Rodenburg, F H van Den Hoogen, P Barrera, et al.
European Journal of Immunology|November 9, 2000
Characterization of recombinant human autoantibody fragments directed toward the autoantigenic U1-70K proteinW G Degen, M Pieffers, E Welin-Henriksson, et al.
The Journal of Clinical Investigation|February 14, 1998
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodiesG A Schellekens, B A de Jong, F H van den Hoogen, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Nederlands Tijdschrift Voor Geneeskunde|August 20, 2003
[The anti-synthetase syndrome: muscle disease and multisystem disorder at the same time]G J Hengstman, W J van Venrooij, F H van den Hoogen, et al.
Journal of Immunological Methods|January 23, 1999
Peripheral blood monocytes of rheumatoid arthritis patients do not express elevated TNF alpha, IL-1beta, and IL-8 mRNA levels. A comparison of monocyte isolation proceduresR J Rodenburg, F H van den Hoogen, L B van de Putte, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 1994
Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damageG T Venneker, F H van den Hoogen, A M Boerbooms, et al.
Acta Orthopaedica Scandinavica|June 1, 1997
Shoulder hemiarthroplasty in rheumatoid arthritis. 19 cases reexamined after 1-17 yearsR C Koorevaar, N D Merkies, M C de Waal Malefijt, et al.
American Journal of Medical Genetics|June 13, 1997
Oto- spondylo-megaepiphyseal dysplasia (OSMED): clinical description of three patients homozygous for a missense mutation in the COL11A2 geneM A van Steensel, P Buma, M C de Waal Malefijt, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 29, 1998
[High-dose chemotherapy followed by hematopoietic stem cell transplantation as therapy for systemic rheumatic autoimmune diseases]F H van den Hoogen, A V Schattenberg, F C Breedveld, et al.
Molecular Biology Reports|May 1, 1992
Analysis of an immunodominant epitope of topoisomerase I in patients with systemic sclerosisT M Meesters, M Hoet, F H van den Hoogen, et al.
Annals of the Rheumatic Diseases|September 24, 1999
Superinduction of interleukin 8 mRNA in activated monocyte derived macrophages from rheumatoid arthritis patientsR J Rodenburg, F H van Den Hoogen, P Barrera, et al.
European Journal of Immunology|November 9, 2000
Characterization of recombinant human autoantibody fragments directed toward the autoantigenic U1-70K proteinW G Degen, M Pieffers, E Welin-Henriksson, et al.
The Journal of Clinical Investigation|February 14, 1998
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodiesG A Schellekens, B A de Jong, F H van den Hoogen, et al.
Pageof 5